In neurodegenerative diseases, the development of brain-penetrant USP30 inhibitors with good drug-like properties may slow down or reverse the progression of diseases like Parkinson’s disease by enhancing mitophagy and improving mitochondrial function, leading to significant breakthroughs. The gene discussed is USP30; the disease is Parkinson disease.